Vectors and methods for the mutagenesis of mammalian genes
CA 2276529 A1 · Owner: Gaitanaris, George A. · Inventors: Gaitanaris, George A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are methods for mutagenizing a mammalian gene the methods , involving introducing into a mammalian cell a retroviral vector which includes a splice acceptor sequence, a transcription termination sequence and , retroviral packaging and integration sequences the introducing step being , carried out under conditions which allow the vector to integrate into the genome of the cell. Also disclosed are retroviral vectors for use in these methods as well as methods for the use of mutagenized cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 31, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 31, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 31, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.